Josep Villanueva Selected Research

Cetuximab (Erbitux)

12/2014

Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josep Villanueva Research Topics

Disease

21	Neoplasms (Cancer) 01/2023 - 03/2004
8	Breast Neoplasms (Breast Cancer) 08/2022 - 03/2009
4	Triple Negative Breast Neoplasms 03/2024 - 01/2020
4	Carcinogenesis 11/2019 - 05/2013
3	Thyroid Neoplasms (Thyroid Cancer) 03/2008 - 07/2005
2	Neoplasm Metastasis (Metastasis) 11/2019 - 12/2018
2	Prostatic Neoplasms (Prostate Cancer) 11/2014 - 01/2006
1	Acidosis 01/2023
1	Inflammation (Inflammations) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2014
1	Starvation 05/2013
1	Brain Neoplasms (Brain Tumor) 03/2004
1	Amyloidosis 09/2003
1	Proteostasis Deficiencies 09/2003

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2003
10	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2006
6	Peptides (Polypeptides)IBA 03/2008 - 09/2003
3	Receptor for Advanced Glycation End ProductsIBA 01/2023 - 11/2019
3	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 05/2013
3	Exopeptidases (Exopeptidase)IBA 11/2014 - 01/2006
2	ChromatinIBA 03/2024 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 08/2022 - 04/2015
2	CytokinesIBA 01/2020 - 05/2015
2	Blood Proteins (Serum Proteins)IBA 05/2013 - 10/2006
2	Complement System Proteins (Complement)IBA 10/2006 - 01/2006
2	Peptide Hydrolases (Proteases)FDA Link 10/2006 - 01/2006
1	Histones (Histone)IBA 03/2024
1	HeterochromatinIBA 03/2024
1	LigandsIBA 01/2023
1	EnzymesIBA 08/2022
1	Superoxide DismutaseIBA 08/2022
1	eribulin FDA Link 05/2022
1	Phosphotransferases (Kinase)IBA 01/2020
1	Promyelocytic Leukemia ProteinIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	AntibodiesIBA 12/2018
1	ProteomeIBA 12/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2015
1	Interleukin-6 (Interleukin 6)IBA 05/2015
1	Cetuximab (Erbitux)FDA Link 12/2014
1	Indicators and Reagents (Reagents)IBA 11/2014
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2014
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2014
1	AminopeptidasesIBA 11/2014
1	Estrogens (Estrogen)FDA Link 12/2010
1	Estrogen ReceptorsIBA 12/2010
1	Growth Factor ReceptorsIBA 12/2010
1	PlasminogenIBA 03/2009
1	Hemostatics (Antihemorrhagics)IBA 03/2008

Therapy/Procedure

3	Therapeutics 08/2022 - 12/2010
1	Neoadjuvant Therapy 08/2022
1	Precision Medicine 01/2020
1	Lasers (Laser) 01/2006